PureTech Health LLC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are AMARIN DEV AB, GUANGDONG P D PHARMACEUTICAL CO LTD and RED HILL BIOPHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Hungary | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Elenko Eric | 11 |
#2 | Miller Andrew C | 9 |
#3 | Bonner Daniel Kenneth | 6 |
#4 | Murray Iii Philip E | 6 |
#5 | Bolen Joseph | 5 |
#6 | Jantz John | 5 |
#7 | Mutamba James Tendai | 5 |
#8 | Ferreira Lisa V | 5 |
#9 | Krumova Katerina | 5 |
#10 | Shyam Rishab R | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020056430A1 | Deuterium-enriched pirfenidone and methods of use thereof | |
WO2018102397A1 | Exosomes for delivery of therapeutic agents | |
US2017095465A1 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |